Biomarkers—A General Review - Aronson - 2017 - Current Protocols in Pharmacology - Wiley Online Library
Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer | British Journal of Cancer
Surrogate Endpoint (Marker): Definition and Examples
PDF) Surrogate vascular input function measurements from the superior sagittal sinus are repeatable and provide tissue-validated kinetic parameters in brain DCE-MRI
IJMS | Free Full-Text | Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review | PLOS ONE
Disease vocabulary size as a surrogate marker for physicians' disease knowledge volume | PLOS ONE
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Surrogate Markers in AIDS Clinical Trials: Conceptual Basis, Validation, and Uncertainties
The place of downstaging for hepatocellular carcinoma - ScienceDirect
Biomarkers of efficacy and safety - European Pharmaceutical Review
Biomarkers of Chronic Kidney Disease - ppt download
Tumor marker /Cancer Biomarkers (Updated)
Surrogate Endpoints And FDA's Accelerated Approval Process | Health Affairs
2 Review: Evaluating and Regulating Biomarker Use | Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease |The National Academies Press
Clinical Outcomes versus Surrogate Endpoints
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Cancers | Free Full-Text | The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Cancers | Free Full-Text | The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status
Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials - The Lancet Diabetes & Endocrinology
Cancers | Free Full-Text | Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
Loss of SDHB expression in SDHx-driven paragangliomas. Loss of SDHB... | Download Scientific Diagram
PDF) Disease vocabulary size as a surrogate marker for physicians' disease knowledge volume
PDF) Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*
